Literature DB >> 22286005

Administration, distribution, metabolism and elimination of polymer therapeutics.

Ela Markovsky1, Hemda Baabur-Cohen, Anat Eldar-Boock, Liora Omer, Galia Tiram, Shiran Ferber, Paula Ofek, Dina Polyak, Anna Scomparin, Ronit Satchi-Fainaro.   

Abstract

Polymer conjugation is an efficient approach to improve the delivery of drugs and biological agents, both by protecting the body from the drug (by improving biodistribution and reducing toxicity) and by protecting the drug from the body (by preventing degradation and enhancing cellular uptake). This review discusses the journey that polymer therapeutics make through the body, following the ADME (absorption, distribution, metabolism, excretion) concept. The biological factors and delivery system parameters that influence each stage of the process will be described, with examples illustrating the different solutions to the challenges of drug delivery systems in vivo.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22286005     DOI: 10.1016/j.jconrel.2011.12.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  42 in total

1.  Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.

Authors:  Jiong Zou; Fuwu Zhang; Shiyi Zhang; Stephanie F Pollack; Mahmoud Elsabahy; Jingwei Fan; Karen L Wooley
Journal:  Adv Healthc Mater       Date:  2013-08-30       Impact factor: 9.933

2.  Degradable PEGylated Protein Conjugates Utilizing RAFT Polymerization.

Authors:  Caitlin G Decker; Heather D Maynard
Journal:  Eur Polym J       Date:  2015-04-01       Impact factor: 4.598

3.  Overcoming obstacles in microRNA delivery towards improved cancer therapy.

Authors:  Dikla Ben-Shushan; Ela Markovsky; Hadas Gibori; Galia Tiram; Anna Scomparin; Ronit Satchi-Fainaro
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

Review 4.  PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

Authors:  Zahid Hussain; Shahzeb Khan; Muhammad Imran; Muhammad Sohail; Syed Wadood Ali Shah; Marcel de Matas
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

5.  Luminescent difluoroboron β-diketonate PEG-PLA oxygen nanosensors for tumor imaging.

Authors:  Jelena Samonina-Kosicka; Douglas H Weitzel; Christina L Hofmann; Hansford Hendargo; Gabi Hanna; Mark W Dewhirst; Gregory M Palmer; Cassandra L Fraser
Journal:  Macromol Rapid Commun       Date:  2015-03-09       Impact factor: 5.734

6.  A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.

Authors:  Aniruddha Roy; Mark J Ernsting; Elijus Undzys; Shyh-Dar Li
Journal:  Biomaterials       Date:  2015-03-03       Impact factor: 12.479

Review 7.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

8.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11

Review 9.  Polymer-drug conjugates: origins, progress to date and future directions.

Authors:  Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

10.  Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting.

Authors:  Homan Kang; Sunghoon Rho; Wesley R Stiles; Shuang Hu; Yoonji Baek; Do Won Hwang; Satoshi Kashiwagi; Moon Suk Kim; Hak Soo Choi
Journal:  Adv Healthc Mater       Date:  2019-12-03       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.